Overview The past week brought important signals on continental immunization strategies (Africa), local manufacturing (South Africa, India), next generation COVID-19 and mucosal vaccines (Europe, Asia–Pacific), and...
As the world reaches the midpoint of the Immunization Agenda 2030 (IA2030), immunization programs find themselves at an inflection point.1 The initial focus on recovering from pandemic-era backsliding is giving way to a...
Download Infographic Overview Climate change and increased human mobility are altering the risk patterns of vaccine-preventable diseases (VPDs). Rising temperatures, changing rainfall, and extreme weather events affect...
North America – Politics First, Evidence Second US vaccine policy spent the week in committee rooms and courtrooms, as reforms to ACIP processes and federal advisory structures drew fire from professional societies and...
“Shared decision‑making” sounds benign, even progressive. Who would object to clinicians and families talking through risks and benefits together? Yet as it is currently being applied to vaccination, “shared...
Download Infographic Overview Vaccine development starts by assessing unmet medical need, often with limited epidemiological data. A Target Product Profile (TPP) defines key vaccine characteristics and guides...
What is EUVABECO? The EUVABECO project — short for European Vaccination Beyond COVID-19 — is a major initiative funded under the EU4Health programme, aiming to translate lessons from the COVID-19 pandemic into durable...
The processes around vaccine licensure today are still built on a shared core: robust evidence for quality, safety, and efficacy, demonstrated through standardized preclinical testing, phased clinical trials, and...
Europe kicked off 2026 by adding more brains to the vaccine bureaucracy, designating a new WHO Collaborating Centre to help NITAGs turn messy evidence into cleaner policy decisions. In theory, this means fewer hand‑wavy...
Download Infographic Overview This infographic shows how vaccines help fight antimicrobial resistance (AMR) by preventing infections before antibiotics are needed. It presents a simple causal chain: fewer infections →...